Schematic diagram for predicting the therapeutic efficacy (IMAGE)
Caption
(A) For the bioorthogonal labeling, unnatural azide groups on the hEPC surface are generated with Ac4ManNAz pretreatment. Then, azide groups of hEPCs are labeled with DBCO-Cy5 via bioorthogonal copper-free click chemistry in vitro (B) Bioorthogonally labeled hEPCs (Cy5-hEPCs) are imaged in hind limb ischemia model via non-invasive FMT for 28 days. The FMT image shows the initial shape of transplanted Cy5-hEPCs is closely correlated to the therapeutic efficacy of stem cells. The condensed round shape of transplanted Cy5-hEPCs can enhance the therapeutic efficacy, compared to spread shape of transplanted Cy5-hEPCs in ischemic site.
Credit
Korea Institute of Science and Technology(KIST)
Usage Restrictions
The sources of photos and research results from KIST must be specified.
License
Licensed content